Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q3 FY25 results · Oct–Dec 2024
Krishna Institute of Medical Sciences reported revenue from operations of ₹772.40 crore (up 27.5% from Q3 FY24) and net profit of ₹92.50 crore (up 20.8% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 772.40 | 605.84 | +27.5% | 777.30 | −0.6% |
| Other income | 17.80 | 3.25 | +446.9% | 5.00 | +256.0% |
| Total income | 790.20 | 609.09 | +29.7% | 782.30 | +1.0% |
| Profit before tax | 134.60 | 102.57 | +31.2% | 162.20 | −17.0% |
| Net profit for the period | 92.50 | 76.55 | +20.8% | 120.70 | −23.4% |
| EPS, basic (₹) | 2.22 | 8.98 | not comparable | 2.68 | −17.2% |
| Net margin (%) | 12.0 | 12.6 | 15.5 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 347.50 | 302.06 | +15.0% | 363.30 | −4.3% |
| Other income | 20.60 | 4.23 | +387.3% | 6.60 | +212.1% |
| Total income | 368.10 | 306.29 | +20.2% | 369.90 | −0.5% |
| Profit before tax | 101.90 | 77.71 | +31.1% | 99.10 | +2.8% |
| Net profit for the period | 76.50 | 58.35 | +31.1% | 72.20 | +6.0% |
| EPS, basic (₹) | 1.91 | 7.29 | not comparable | 1.80 | +6.1% |
| Net margin (%) | 22.0 | 19.3 | 19.9 |
Consolidated
- Filed with BSE
- 06 Feb 2025, 19:08 IST
- Board meeting
- 06 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Feb 2025, 19:08 IST
- Board meeting
- 06 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE